Dermira (DERM) Tops Q3 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Dermira (DERM) Tops Q3 EPS by 11c

Journey Medical Corporation Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights

November 10, 2022 4:01 PM EST

Revenue for the first nine months of 2022 increased 26% to $57.7 million versus the same period in 2021 of $45.6 million

DFD-29 Phase 3 studies are 75% enrolled to date

Top-line data from the Phase 3 clinical program evaluating DFD-29 for the treatment of papulopustular rosacea anticipated in the first half of 2023

Company to hold conference call on November 10, 2022 at 4:30 p.m. ET

SCOTTSDALE, Ariz., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (Journey Medical or the Company), a commercial-stage pharmaceutical company that focuses on the... More